Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
16.21B | 16.68B | 18.23B | 14.92B | 11.27B | 12.72B | Gross Profit |
2.73B | 2.79B | 3.64B | 3.36B | 1.85B | 2.16B | EBIT |
428.20M | 569.30M | 1.70B | 1.46B | 340.50M | -89.00M | EBITDA |
1.35B | 1.74B | 2.42B | 2.22B | 1.11B | 795.30M | Net Income Common Stockholders |
12.30M | 100.80M | 1.06B | 1.30B | 42.10M | -208.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
444.30M | 1.48B | 1.40B | 988.40M | 1.30B | 850.10M | Total Assets |
15.33B | 16.56B | 17.09B | 17.02B | 14.91B | 14.97B | Total Debt |
0.00 | 3.06B | 2.99B | 3.19B | 3.98B | 4.54B | Net Debt |
-346.20M | 1.74B | 1.94B | 2.34B | 2.82B | 3.75B | Total Liabilities |
7.90B | 9.06B | 9.32B | 9.96B | 9.26B | 9.35B | Stockholders Equity |
7.18B | 7.19B | 7.53B | 6.91B | 5.52B | 5.48B |
Cash Flow | Free Cash Flow | ||||
287.60M | 366.00M | 204.10M | 588.90M | 1.03B | 556.10M | Operating Cash Flow |
1.40B | 1.45B | 956.20M | 1.24B | 1.63B | 1.30B | Investing Cash Flow |
-763.80M | -853.00M | -47.10M | -629.80M | -665.80M | -606.80M | Financing Cash Flow |
-1.12B | -325.30M | -685.90M | -948.30M | -595.60M | -374.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $16.29B | 22.21 | 10.27% | 1.55% | -5.60% | -35.05% | |
73 Outperform | $28.20B | 21.76 | 6.54% | 1.80% | -10.88% | -66.97% | |
72 Outperform | $19.61B | 17.46 | 13.08% | 1.54% | -7.42% | -48.08% | |
67 Neutral | $25.42B | 18.06 | 2.60% | 0.76% | -8.56% | 68.36% | |
64 Neutral | $12.42B | 186.15 | 0.86% | 0.36% | -14.79% | -88.78% | |
62 Neutral | $4.65B | 27.09 | 2.14% | 2.88% | -5.73% | -110.50% | |
51 Neutral | $2.01B | -1.26 | -21.11% | 4.38% | 2.92% | -30.46% |